REVIEW article

Front. Pharmacol.

Sec. Ethnopharmacology

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1565332

Natural Products Target Programmed Cell Death Signaling Mechanisms to Treat Colorectal Cancer

Provisionally accepted
ya  zhengya zheng1Na  FengNa Feng2Canglin  LiCanglin Li1Zuoqiang  LiZuoqiang Li3*
  • 1Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China
  • 2Linyi Maternity and Child Health Care Hospital, Linyi, Shandong Province, China
  • 3Shandong Academy of Occupational Health and Occupational Medicine, Jinan, Shandong Province, China

The final, formatted version of the article will be published soon.

As a highly prevalent gastrointestinal malignant tumor, colorectal cancer poses a serious challenge in terms of increasing morbidity and mortality and late diagnosis due to the invisibility of the disease. Although existing therapies are diverse but limited in efficacy, the mechanism of programmed cell death (PCD) has become a focus of research due to its central role in maintaining body homeostasis and regulating tumor progression. Multimodal cell death pathways, such as apoptosis, autophagy, pyroptosis and ferroptosis, have shown unique advantages in inhibiting the proliferation and migration of colorectal cancer cells and enhancing the sensitivity to chemotherapy by responding to internal and external environmental stimuli. In recent years, natural products have risen to prominence by virtue of their multi-target synergistic effects and chemo-sensitizing properties, and have opened up a new direction for colorectal cancer treatment by precisely regulating the PCD pathway. In this paper, we searched PubMed, Web of Science and CNKI databases for relevant studies in the last 10 years using the keywords (Colorectal cancer) and (programmed cell death) and natural products. This work retrieved 59 studies (55 from the past 5 years and 4 from the past 10 years) to reveal the mechanism of action of natural products targeting PCD, aiming to provide theoretical support and practical guidance for the optimization of clinical therapeutic strategies and the development of innovative drugs.

Keywords: CRC, PCD, natural product, Mechanism, Chinese medicine, Drug Resistance

Received: 23 Jan 2025; Accepted: 08 Apr 2025.

Copyright: © 2025 zheng, Feng, Li and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Zuoqiang Li, Shandong Academy of Occupational Health and Occupational Medicine, Jinan, 250062, Shandong Province, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.